Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | NVAX |
---|---|---|
09:32 ET | 92200 | 7.84 |
09:33 ET | 10174 | 7.7733 |
09:35 ET | 9180 | 7.78 |
09:37 ET | 17602 | 7.75 |
09:39 ET | 13194 | 7.73 |
09:42 ET | 15508 | 7.71 |
09:44 ET | 12649 | 7.73 |
09:46 ET | 14891 | 7.715 |
09:48 ET | 9627 | 7.7 |
09:50 ET | 26890 | 7.68 |
09:51 ET | 15506 | 7.6783 |
09:53 ET | 3322 | 7.74 |
09:55 ET | 5866 | 7.76 |
09:57 ET | 8567 | 7.745 |
10:00 ET | 10899 | 7.76 |
10:02 ET | 7833 | 7.72 |
10:04 ET | 14559 | 7.7017 |
10:06 ET | 14572 | 7.69 |
10:08 ET | 4099 | 7.73 |
10:09 ET | 7254 | 7.78 |
10:11 ET | 9648 | 7.805 |
10:13 ET | 18803 | 7.815 |
10:15 ET | 12953 | 7.83 |
10:18 ET | 30731 | 7.805 |
10:20 ET | 4265 | 7.79 |
10:22 ET | 8327 | 7.79 |
10:24 ET | 8747 | 7.79 |
10:26 ET | 9205 | 7.82 |
10:27 ET | 5022 | 7.81 |
10:29 ET | 6761 | 7.8 |
10:31 ET | 5700 | 7.79 |
10:33 ET | 11747 | 7.79 |
10:36 ET | 6454 | 7.8 |
10:38 ET | 14522 | 7.8 |
10:40 ET | 25882 | 7.8 |
10:42 ET | 10323 | 7.8 |
10:44 ET | 10574 | 7.82 |
10:45 ET | 17440 | 7.79 |
10:47 ET | 6872 | 7.76 |
10:49 ET | 5603 | 7.765 |
10:51 ET | 16456 | 7.77 |
10:54 ET | 3495 | 7.7793 |
10:56 ET | 9184 | 7.735 |
10:58 ET | 22189 | 7.76 |
11:00 ET | 1753 | 7.76 |
11:02 ET | 3998 | 7.7405 |
11:03 ET | 9240 | 7.764 |
11:05 ET | 1717 | 7.765 |
11:07 ET | 26156 | 7.78 |
11:09 ET | 35450 | 7.845 |
11:12 ET | 10014 | 7.85 |
11:14 ET | 18000 | 7.87 |
11:16 ET | 4736 | 7.875 |
11:18 ET | 23314 | 7.91 |
11:20 ET | 16100 | 7.9 |
11:21 ET | 22018 | 7.8713 |
11:23 ET | 20713 | 7.93 |
11:25 ET | 10409 | 7.945 |
11:27 ET | 28485 | 7.96 |
11:30 ET | 9404 | 7.97 |
11:32 ET | 1410 | 7.9756 |
11:34 ET | 24899 | 7.95 |
11:36 ET | 13446 | 7.91 |
11:38 ET | 13087 | 7.92 |
11:39 ET | 7445 | 7.9 |
11:41 ET | 26986 | 7.91 |
11:43 ET | 7840 | 7.8915 |
11:45 ET | 16020 | 7.89 |
11:48 ET | 5258 | 7.895 |
11:50 ET | 2352 | 7.895 |
11:52 ET | 7215 | 7.875 |
11:54 ET | 14017 | 7.91 |
11:56 ET | 13284 | 7.945 |
11:57 ET | 7173 | 7.95 |
11:59 ET | 30973 | 7.9768 |
12:01 ET | 26895 | 7.985 |
12:03 ET | 19044 | 7.91 |
12:06 ET | 4884 | 7.895 |
12:08 ET | 16796 | 7.92 |
12:10 ET | 19727 | 7.95 |
12:12 ET | 7280 | 7.935 |
12:14 ET | 23228 | 7.98 |
12:15 ET | 2450 | 7.98 |
12:17 ET | 7748 | 7.97 |
12:19 ET | 19669 | 7.985 |
12:21 ET | 29506 | 7.98 |
12:24 ET | 17886 | 7.98 |
12:26 ET | 5088 | 7.9948 |
12:28 ET | 23760 | 7.9919 |
12:30 ET | 12875 | 8.0001 |
12:32 ET | 16309 | 7.995 |
12:33 ET | 23304 | 7.97 |
12:35 ET | 23143 | 7.95 |
12:37 ET | 1306 | 7.94 |
12:39 ET | 2740 | 7.935 |
12:42 ET | 3051 | 7.945 |
12:44 ET | 13999 | 7.925 |
12:46 ET | 9524 | 7.91 |
12:48 ET | 25163 | 7.89 |
12:50 ET | 3360 | 7.88 |
12:51 ET | 17798 | 7.925 |
12:53 ET | 4932 | 7.9315 |
12:55 ET | 17712 | 7.915 |
12:57 ET | 47600 | 7.88 |
01:00 ET | 18549 | 7.9 |
01:02 ET | 17005 | 7.88 |
01:04 ET | 17982 | 7.8649 |
01:06 ET | 5888 | 7.8606 |
01:08 ET | 47339 | 7.841 |
01:09 ET | 19210 | 7.87 |
01:11 ET | 5957 | 7.88 |
01:13 ET | 3380 | 7.88 |
01:15 ET | 12251 | 7.865 |
01:18 ET | 42963 | 7.94 |
01:20 ET | 20520 | 7.965 |
01:22 ET | 15810 | 7.96 |
01:24 ET | 27527 | 8.0001 |
01:26 ET | 27603 | 8.004 |
01:27 ET | 44657 | 7.975 |
01:29 ET | 28639 | 8 |
01:31 ET | 2614 | 8.0002 |
01:33 ET | 4826 | 8.0026 |
01:36 ET | 5636 | 8.01 |
01:38 ET | 46356 | 8.016 |
01:40 ET | 24330 | 8.01 |
01:42 ET | 40815 | 8.005 |
01:44 ET | 18997 | 8 |
01:45 ET | 2800 | 8.005 |
01:47 ET | 14814 | 8 |
01:49 ET | 9041 | 8.005 |
01:51 ET | 10750 | 8.01 |
01:54 ET | 27825 | 8.01 |
01:56 ET | 4705 | 8.03 |
01:58 ET | 41918 | 8.04 |
02:00 ET | 30871 | 8.05 |
02:02 ET | 11564 | 8.0578 |
02:03 ET | 31957 | 8.06 |
02:05 ET | 1301 | 8.0529 |
02:07 ET | 8972 | 8.05 |
02:09 ET | 3532 | 8.04 |
02:12 ET | 30573 | 8.065 |
02:14 ET | 51861 | 8.085 |
02:16 ET | 11898 | 8.09 |
02:18 ET | 21373 | 8.055 |
02:20 ET | 29568 | 8.03 |
02:21 ET | 2962 | 8.025 |
02:23 ET | 35630 | 8.07 |
02:25 ET | 7270 | 8.06 |
02:27 ET | 13669 | 8.055 |
02:30 ET | 28777 | 8.05 |
02:32 ET | 9439 | 8.015 |
02:34 ET | 8514 | 8 |
02:36 ET | 6490 | 8.011 |
02:38 ET | 5639 | 8.0212 |
02:39 ET | 3919 | 8.015 |
02:41 ET | 1600 | 8.02 |
02:43 ET | 3220 | 8 |
02:45 ET | 3018 | 8.01 |
02:48 ET | 44988 | 8.04 |
02:50 ET | 12434 | 8.0201 |
02:52 ET | 6093 | 8.03 |
02:54 ET | 5955 | 8.045 |
02:56 ET | 10061 | 8.035 |
02:57 ET | 35543 | 8.0048 |
02:59 ET | 7128 | 7.99 |
03:01 ET | 23336 | 7.995 |
03:03 ET | 48324 | 7.97 |
03:06 ET | 5238 | 7.98 |
03:08 ET | 11676 | 7.9849 |
03:10 ET | 16882 | 8.005 |
03:12 ET | 12832 | 8 |
03:14 ET | 13015 | 7.965 |
03:15 ET | 17861 | 7.935 |
03:17 ET | 17271 | 7.955 |
03:19 ET | 2412 | 7.96 |
03:21 ET | 8847 | 7.97 |
03:24 ET | 19402 | 7.97 |
03:26 ET | 8711 | 7.965 |
03:28 ET | 4152 | 7.97 |
03:30 ET | 36677 | 7.97 |
03:32 ET | 7682 | 7.97 |
03:33 ET | 18471 | 7.96 |
03:35 ET | 11561 | 7.955 |
03:37 ET | 52037 | 7.98 |
03:39 ET | 3719 | 7.98 |
03:42 ET | 9696 | 7.99 |
03:44 ET | 9761 | 7.985 |
03:46 ET | 17921 | 7.975 |
03:48 ET | 23344 | 7.985 |
03:50 ET | 28382 | 7.98 |
03:51 ET | 29240 | 7.965 |
03:53 ET | 57232 | 8 |
03:55 ET | 48480 | 7.995 |
03:57 ET | 41773 | 8 |
04:00 ET | 508986 | 8 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Novavax Inc | 1.3B | -3.5x | --- |
Azenta Inc | 2.0B | -13.8x | --- |
P3 Health Partners Inc | 75.4M | -0.3x | --- |
ACADIA Pharmaceuticals Inc | 2.7B | 20.9x | --- |
Inotiv Inc | 72.6M | -0.7x | --- |
Sinovac Biotech Ltd | 639.9M | -4.9x | --- |
Novavax, Inc. is a biotechnology company, which discovers, develops and commercializes vaccines to prevent serious infectious diseases. The Company offers a differentiated vaccine platform that combines a recombinant protein approach, advanced nanoparticle technology and its patented Matrix-M adjuvant to enhance the immune response. It has one commercial program, for vaccines to prevent COVID-19, which includes Nuvaxovid prototype COVID-19 vaccine (NVX-CoV2373 or prototype vaccine) and Nuvaxovid updated COVID-19 vaccine (NVX-CoV2601 or updated vaccine) (collectively, COVID-19 Vaccine). The Company is advancing the development of other vaccine candidates, including its COVID19-Influenza Combination (CIC) vaccine candidate and additional vaccine candidates. Its COVID-19 Vaccine and its other vaccine candidates incorporate the Company’s proprietary Matrix-M adjuvant to enhance the immune response and stimulate higher levels of functional antibodies and induce a cellular immune response.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.3B |
---|---|
Revenue (TTM) | $885.2M |
Shares Outstanding | 160.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.03 |
EPS | $-2.26 |
Book Value | $-5.14 |
P/E Ratio | -3.5x |
Price/Sales (TTM) | 1.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -34.05% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.